Neumora upgraded at RBC Capital Markets on obesity, Parkinson's asset
2025-12-01 14:34:09 ET
More on Neumora Therapeutics
- Neumora Therapeutics, Inc. (NMRA) Discusses NMRA-215 Preclinical Results and Portfolio Updates, Including Obesity and Alzheimer's Disease Programs - Slideshow
- Neumora Therapeutics, Inc. (NMRA) Discusses NMRA-215 Preclinical Results and Portfolio Updates, Including Obesity and Alzheimer's Disease Programs Transcript
- Neumora to initiate phase 1 study of oral obesity pill
- Seeking Alpha’s Quant Rating on Neumora Therapeutics
- Historical earnings data for Neumora Therapeutics
Read the full article on Seeking Alpha
For further details see:
Neumora upgraded at RBC Capital Markets on obesity, Parkinson's assetNASDAQ: NMRA
NMRA Trading
6.22% G/L:
$3.16 Last:
503,274 Volume:
$3 Open:



